EMA — authorised 26 March 2021
- Marketing authorisation holder: TEVA B.V.
- Status: approved
🇪🇺 Cutivate in European Union
EMA authorised Cutivate on 26 March 2021
Marketing authorisation
Cutivate in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Cutivate approved in European Union?
Yes. EMA authorised it on 26 March 2021.
Who is the marketing authorisation holder for Cutivate in European Union?
TEVA B.V. holds the EU marketing authorisation.